tiprankstipranks
HLS Therapeutics Inc (DE:74D)
FRANKFURT:74D
Germany Market
74D
HLS Therapeutics Inc
RESEARCH TOOLSreports

HLS Therapeutics Inc (74D) Ratios

0 Followers

HLS Therapeutics Inc Ratios

DE:74D's free cash flow for Q2 2026 was $0.43. For the 2026 fiscal year, DE:74D's free cash flow was decreased by $ and operating cash flow was $-0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.05 1.11 1.57 1.65 1.42
Quick Ratio
 0.84 0.80 1.17 1.30 1.14
Cash Ratio
 0.47 0.45 0.77 0.82 0.66
Solvency Ratio
 0.18 0.13 0.03 0.04 0.09
Operating Cash Flow Ratio
 0.62 0.61 0.35 0.59 0.54
Short-Term Operating Cash Flow Coverage
 4.35 3.70 1.66 3.37 1.30
Net Current Asset Value
$ -42.80M$ -46.68M$ -53.16M$ -67.27M$ -71.96M
Leverage Ratios
Debt-to-Assets Ratio
 0.33 0.36 0.42 0.42 0.40
Debt-to-Equity Ratio
 0.76 0.81 0.93 0.90 0.78
Debt-to-Capital Ratio
 0.43 0.45 0.48 0.47 0.44
Long-Term Debt-to-Capital Ratio
 0.40 0.42 0.46 0.46 0.40
Financial Leverage Ratio
 2.33 2.23 2.24 2.14 1.93
Debt Service Coverage Ratio
 2.10 1.60 0.88 0.98 0.89
Interest Coverage Ratio
 -0.91 -0.58 -0.76 -1.18 -1.84
Debt to Market Cap
 0.47 0.44 0.75 0.90 0.41
Interest Debt Per Share
 1.38 1.81 2.40 2.99 3.24
Net Debt to EBITDA
 1.54 2.11 2.85 5.10 4.26
Profitability Margins
Gross Profit Margin
61.41%42.52%84.11%87.91%91.90%
EBIT Margin
-6.56%-7.40%-9.71%-30.21%-26.69%
EBITDA Margin
32.60%31.91%30.41%20.43%29.28%
Operating Profit Margin
-7.95%-7.40%-13.57%-16.41%-21.87%
Pretax Profit Margin
-16.37%-23.20%-27.52%-44.08%-38.59%
Net Profit Margin
-15.20%-22.40%-34.71%-43.65%-38.39%
Continuous Operations Profit Margin
-15.20%-22.40%-34.71%-43.65%-38.39%
Net Income Per EBT
92.85%96.54%126.14%99.02%99.48%
EBT Per EBIT
206.04%313.57%202.73%268.65%176.50%
Return on Assets (ROA)
-6.66%-9.21%-12.29%-13.17%-9.77%
Return on Equity (ROE)
-14.43%-20.55%-27.55%-28.18%-18.83%
Return on Capital Employed (ROCE)
-4.50%-3.76%-5.60%-5.67%-6.39%
Return on Invested Capital (ROIC)
-3.99%-3.48%-5.39%-5.46%-5.97%
Return on Tangible Assets
-25.83%-39.72%-52.02%-58.93%-50.60%
Earnings Yield
-8.93%-11.43%-22.60%-28.65%-10.07%
Efficiency Ratios
Receivables Turnover
 6.62 7.20 7.52 5.90 5.49
Payables Turnover
 2.59 3.12 1.03 0.54 0.43
Inventory Turnover
 3.54 4.00 0.99 0.80 0.56
Fixed Asset Turnover
 55.03 42.28 56.79 65.36 54.54
Asset Turnover
 0.44 0.41 0.35 0.30 0.25
Working Capital Turnover Ratio
 72.81 7.14 3.74 4.12 4.20
Cash Conversion Cycle
 17.18 24.92 62.67 -157.05 -130.57
Days of Sales Outstanding
 55.15 50.72 48.51 61.88 66.47
Days of Inventory Outstanding
 103.10 91.36 367.47 456.44 652.32
Days of Payables Outstanding
 141.07 117.16 353.32 675.37 849.37
Operating Cycle
 158.25 142.08 415.99 518.33 718.80
Cash Flow Ratios
Operating Cash Flow Per Share
 0.53 0.51 0.25 0.49 0.52
Free Cash Flow Per Share
 0.52 0.50 0.25 0.48 0.21
CapEx Per Share
 0.01 <0.01 <0.01 <0.01 0.31
Free Cash Flow to Operating Cash Flow
 0.98 0.99 1.00 0.99 0.40
Dividend Paid and CapEx Coverage Ratio
 48.59 76.79 533.53 6.10 1.12
Capital Expenditure Coverage Ratio
 48.59 76.79 533.53 83.54 1.67
Operating Cash Flow Coverage Ratio
 0.43 0.32 0.12 0.18 0.17
Operating Cash Flow to Sales Ratio
 0.32 0.28 0.14 0.25 0.28
Free Cash Flow Yield
20.10%14.29%9.19%16.24%2.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -10.61 -8.77 -4.40 -3.49 -9.93
Price-to-Sales (P/S) Ratio
 1.57 1.96 1.54 1.52 3.81
Price-to-Book (P/B) Ratio
 1.74 1.80 1.22 0.98 1.87
Price-to-Free Cash Flow (P/FCF) Ratio
 4.98 7.00 10.89 6.16 34.50
Price-to-Operating Cash Flow Ratio
 5.30 6.91 10.86 6.09 13.84
Price-to-Earnings Growth (PEG) Ratio
 -0.17 0.25 0.16 -0.21 -0.13
Price-to-Fair Value
 1.74 1.80 1.22 0.98 1.87
Enterprise Value Multiple
 6.34 8.25 7.90 12.55 17.28
Enterprise Value
 116.37M 148.68M 135.95M 161.75M 311.04M
EV to EBITDA
 6.34 8.25 7.90 12.55 17.28
EV to Sales
 2.07 2.63 2.40 2.56 5.06
EV to Free Cash Flow
 6.57 9.41 17.02 10.37 45.78
EV to Operating Cash Flow
 6.43 9.28 16.99 10.24 18.36
Tangible Book Value Per Share
 -1.18 -1.39 -1.59 -2.00 -2.16
Shareholders’ Equity Per Share
 1.62 1.95 2.24 3.03 3.88
Tax and Other Ratios
Effective Tax Rate
 0.07 0.03 -0.26 <0.01 <0.01
Revenue Per Share
 1.66 1.79 1.78 1.95 1.90
Net Income Per Share
 -0.25 -0.40 -0.62 -0.85 -0.73
Tax Burden
 0.93 0.97 1.26 0.99 0.99
Interest Burden
 2.50 3.14 2.83 1.46 1.45
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.39 0.39 0.48 0.13 0.29
Stock-Based Compensation to Revenue
 0.02 0.03 0.03 >-0.01 0.05
Income Quality
 -2.11 -1.29 -0.41 -0.57 -0.72
Currency in USD